1. Home
  2. OLMA vs GPRE Comparison

OLMA vs GPRE Comparison

Compare OLMA & GPRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • GPRE
  • Stock Information
  • Founded
  • OLMA 2006
  • GPRE 2004
  • Country
  • OLMA United States
  • GPRE United States
  • Employees
  • OLMA N/A
  • GPRE N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • GPRE Major Chemicals
  • Sector
  • OLMA Health Care
  • GPRE Industrials
  • Exchange
  • OLMA Nasdaq
  • GPRE Nasdaq
  • Market Cap
  • OLMA 725.5M
  • GPRE 631.4M
  • IPO Year
  • OLMA 2020
  • GPRE N/A
  • Fundamental
  • Price
  • OLMA $8.72
  • GPRE $10.34
  • Analyst Decision
  • OLMA Strong Buy
  • GPRE Hold
  • Analyst Count
  • OLMA 6
  • GPRE 7
  • Target Price
  • OLMA $23.00
  • GPRE $8.50
  • AVG Volume (30 Days)
  • OLMA 1.5M
  • GPRE 2.6M
  • Earning Date
  • OLMA 11-07-2025
  • GPRE 11-11-2025
  • Dividend Yield
  • OLMA N/A
  • GPRE N/A
  • EPS Growth
  • OLMA N/A
  • GPRE N/A
  • EPS
  • OLMA N/A
  • GPRE N/A
  • Revenue
  • OLMA N/A
  • GPRE $2,397,101,000.00
  • Revenue This Year
  • OLMA N/A
  • GPRE N/A
  • Revenue Next Year
  • OLMA N/A
  • GPRE N/A
  • P/E Ratio
  • OLMA N/A
  • GPRE N/A
  • Revenue Growth
  • OLMA N/A
  • GPRE N/A
  • 52 Week Low
  • OLMA $2.86
  • GPRE $3.14
  • 52 Week High
  • OLMA $13.51
  • GPRE $14.04
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 47.84
  • GPRE 50.78
  • Support Level
  • OLMA $7.80
  • GPRE $9.18
  • Resistance Level
  • OLMA $8.48
  • GPRE $11.37
  • Average True Range (ATR)
  • OLMA 0.76
  • GPRE 0.76
  • MACD
  • OLMA -0.31
  • GPRE -0.03
  • Stochastic Oscillator
  • OLMA 44.15
  • GPRE 41.86

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About GPRE Green Plains Inc.

Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.

Share on Social Networks: